(Sharecast News) - Healthcare company Novacyt said it had signed a contract with the UK Department of Health to supply its Covid-19 polymerase chain reaction test.
Novacyt said on Monday that under the terms of the agreement it would supply its Covid-19 test for an initial term of six months, starting from May 4, and had initially committed to supplying 288,000 tests per week.
As of 0945 BST, Novacyt shares had climbed 8.98% to 403.22p.
Novacyt (NCYT)19 Apr 2024 11:02
Novacyt gearing up for hearing in DHSC litigation
(Sharecast News) - Molecular diagnostics specialist Novacyt updated the market on legal proceedings between itself and its subsidiary Primer Design ag...